Natera (NTRA)
(Delayed Data from NSDQ)
$91.66 USD
+0.38 (0.42%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $91.70 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
NTRA 91.66 +0.38(0.42%)
Will NTRA be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for NTRA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NTRA
What Makes Natera (NTRA) a Strong Momentum Stock: Buy Now?
Compared to Estimates, Natera (NTRA) Q4 Earnings: A Look at Key Metrics
NTRA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Agilon Health (AGL) Reports Q4 Loss, Tops Revenue Estimates
Bull of the Day: NeoGenomics (NEO)
Enhabit (EHAB) Lags Q3 Earnings and Revenue Estimates
Other News for NTRA
Insider Sell: CFO Michael Brophy Sells Shares of Natera Inc
Insider Sell: CFO Michael Brophy Sells Shares of Natera Inc (NTRA)
CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)
Artisan Global Equity Fund Q1 2024 Commentary
Baron Health Care Fund Q1 2024 Shareholder Letter